List of life sciences

Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors

Retrieved on: 
Monday, October 24, 2022
Other Health, Health, Science, Research, Oncology, Physician, LinkedIn, Lung, SLN, Uncertainty, Personal Data Privacy and Security Act of 2009, Dermatology, Risk, SEC, Conference, SEER, Patient, Surveillance, Publication, Twitter, List of life sciences, Instagram, Securities Act of 1933, Metastasis, Nasdaq, Sentinel lymph node, Malignancy, Company, Prostate, Medicare, Health, Atopic dermatitis, Skin, Breast, Securities Exchange Act of 1934, Castle, Recurrence, Survival, Melanoma, CSCC, Â, Disease management, Uveal melanoma, 2022 Formula One World Championship, Poster, Medical device, Medical imaging, Facebook, Epidemiology

In this analysis of Medicare-eligible patients with high-risk cSCC (n=59), clinicians indicated that the DecisionDx-SCC test result was the most influential factor impacting their management plans for 42% of the patients.

Key Points: 
  • In this analysis of Medicare-eligible patients with high-risk cSCC (n=59), clinicians indicated that the DecisionDx-SCC test result was the most influential factor impacting their management plans for 42% of the patients.
  • DecisionDx-SCC is a 40-gene expression profile test that uses an individual patients tumor biology to predict individual risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors.
  • The test result, in which patients are stratified into a Class 1 (low), 2A (moderate) or 2B (high) risk category, predicts individual metastatic risk to inform risk-appropriate management.
  • Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.

Fortis Life Sciences Expands Its International Presence

Retrieved on: 
Monday, October 24, 2022
Research, Technology, Other Technology, Software, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, APAC, Doctor of Philosophy, HQ, MNC, Industry, Research, General manager, CEO, List of life sciences, Industrial design, Medical device, Fortis

Fortis Life Sciences, a provider of high-quality reagents and custom services for discovery, development, and manufacturing, has expanded its international presence by opening an office in Seoul, South Korea.

Key Points: 
  • Fortis Life Sciences, a provider of high-quality reagents and custom services for discovery, development, and manufacturing, has expanded its international presence by opening an office in Seoul, South Korea.
  • "With the expanded global demand and sophisticated supply chain in life science, diagnostic, and therapeutic markets, Fortis Life Sciences is answering scientists requests for faster turnaround time, the highest product quality, the best customer experience, and reliable scientific support," said Dr. Yun.
  • Fortis Life Sciences is a strategic platform company founded in 2020 with the mission to offer world-class products coupled with best-in-class customer experience.
  • Over the course of two years, Fortis has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research.

ISAP2022: The 14th International Forum for Sustainable Asia and the Pacific “Strengthening Synergies Between Climate Change and Biodiversity: From Science to Policy to Action”

Retrieved on: 
Tuesday, October 25, 2022
Sustainability, Environment, Environmental, Social and Governance (ESG), Environmental Issues, Climate Change, Professional Services, University, Education, CBD, Element, Communication, Growth, Intergovernmental Panel on Climate Change, Conference, IGES, IPCC, Policy, GBF, 3rd Plenary Session of the 11th Central Committee of the Chinese Communist Party, Tohoku University, Research, United Nations Framework Convention on Climate Change, Institute, Senior, Biodiversity, Solution, Graduate school, Convention, Intergovernmental, Face, International Forum on Energy Security for the Future, ISAP, Climate change, Biology, Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services, Pacifico Yokohama, UNFCCC, IPBES, List of life sciences, COP27, Agriculture, COP15, Science, Pacific Ocean

The Institute for Global Environmental Strategies (IGES) will host the 14th International Forum for Sustainable Asia and the Pacific (ISAP2022).

Key Points: 
  • The Institute for Global Environmental Strategies (IGES) will host the 14th International Forum for Sustainable Asia and the Pacific (ISAP2022).
  • Held in Japan, ISAP is an annual forum that features a range of discussions on sustainable development in Asia and the Pacific through Plenary Sessions and Thematic Tracks.
  • The overall theme of ISAP2022 is Strengthening Synergies between Climate Change and Biodiversity: From Science to Policy to Action, focusing on integration across two of the worlds most pressing environmental challenges: climate action and biodiversity conservation.
  • It would also help anticipate and find a balance on climate change and biodiversity trade-offs, which tend not to be discussed much.

Loftware Prisym 360 Version 1.16 Strengthens 'All-In-One' Clinical Trials Labeling Solution with New Features to Deliver Efficiencies and Simplify Compliance

Retrieved on: 
Wednesday, October 26, 2022
Pressure, Risk, Electronics, Efficiency, Growth, SOAP, Clinical data management, Organization, Web service, Senior, GxP, Industry, Content management, Foodservice, Clinical trial, NEMS Enterprises (label), Random modulation, REST, List of life sciences, Compliance, Communications manager, Medical device, Video game console, Dietary supplement

PORTSMOUTH, N.H., Oct. 26, 2022 /PRNewswire/ -- Loftware, the global leader in Enterprise Labeling and Artwork Management solutions, today announced the availability of Loftware Prisym 360 1.16. The latest release of Loftware's cloud-based clinical trials label and content management solution adds two new features designed to increase the efficiency of clinical trial supplies operations while reducing risk and simplifying compliance.

Key Points: 
  • The latest release of Loftware's cloud-based clinical trials label and content management solution adds two new features designed to increase the efficiency of clinical trial supplies operations while reducing risk and simplifying compliance.
  • Prisym 360 1.16 introduces a new Clinical Data Connector, which streamlines the end-to-end clinical labeling process by connecting clinical supplies applications to Prisym 360's label and booklet design features.
  • The Prisym 360 Clinical Data Connector, developed with input from best-of-breed Clinical Supplies Management vendors, such as Signant Health, helps simplify inter-connection with Prisym 360, thereby removing the need for manual data entry.
  • The Prisym 360 Clinical Data Connector and Data Randomization modules are now available as part of the latest 1.16 product release of Prisym 360.

Loftware Prisym 360 Version 1.16 Strengthens 'All-In-One' Clinical Trials Labeling Solution with New Features to Deliver Efficiencies and Simplify Compliance

Retrieved on: 
Wednesday, October 26, 2022
Pressure, Risk, Electronics, Efficiency, Growth, SOAP, Clinical data management, Organization, Web service, GxP, Industry, Content management, Foodservice, Clinical trial, NEMS Enterprises (label), Random modulation, REST, List of life sciences, Compliance, Medical device, Video game console, Dietary supplement

PORTSMOUTH, N.H., Oct. 26, 2022 /PRNewswire/ -- Loftware, the global leader in Enterprise Labeling and Artwork Management solutions, today announced the availability of Loftware Prisym 360 1.16. The latest release of Loftware's cloud-based clinical trials label and content management solution adds two new features designed to increase the efficiency of clinical trial supplies operations while reducing risk and simplifying compliance.

Key Points: 
  • The latest release of Loftware's cloud-based clinical trials label and content management solution adds two new features designed to increase the efficiency of clinical trial supplies operations while reducing risk and simplifying compliance.
  • Prisym 360 1.16 introduces a new Clinical Data Connector, which streamlines the end-to-end clinical labeling process by connecting clinical supplies applications to Prisym 360's label and booklet design features.
  • The Prisym 360 Clinical Data Connector, developed with input from best-of-breed Clinical Supplies Management vendors, such as Signant Health, helps simplify inter-connection with Prisym 360, thereby removing the need for manual data entry.
  • The Prisym 360 Clinical Data Connector and Data Randomization modules are now available as part of the latest 1.16 product release of Prisym 360.

Clarivate Identifies the Role of Research and Innovation in the World's Shift to Sustainable Energy

Retrieved on: 
Wednesday, October 26, 2022
Data collection, Health care, Technology, List of life sciences, VP, Gaps, NYSE, Intelligence, Professional services, Research, Mainland Chinese, DWPI, Industry, Geography, White, Collection, Invention, Infrastructure, Derwent World Patents Index, Web of Science, CEO, Ecosystem, IP, Patent, Clarivate, Innovation, Overalls, Academy, Final good, Derwent, Policy, Solution, Fraunhofer Institute for Systems and Innovation Research ISI, Renewable energy, Weapon

LONDON, Oct. 26, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report, A study of energy in transition: the role of research and innovation in the world's shift to sustainable energy sources. It finds that innovation activity in the sustainable energy space is tailing off, as research and inventive activities for respective renewable develops at different paces. This finding is based on Clarivate data normalized for overall increases in scientific journal and patent output increases globally in all subject areas.

Key Points: 
  • It finds that innovation activity in the sustainable energy space is tailing off, as research and inventive activities for respective renewable develops at different paces.
  • Oceanic power generation currently falls within the immature scale of the report's sustainable energy sources maturity index,2despite oceanic power, with its high energy density, being seen as one of the most promising sustainable energy sources if fully harnessed.
  • From a geographic perspective, Mainland China tops global research and innovation output in renewable energy sources, strengthening its international stature as a research and innovation powerhouse.
  • It looks at the relationship between global research and innovation in the roll out and development of sustainable energy sources.

Clarivate Identifies the Role of Research and Innovation in the World's Shift to Sustainable Energy

Retrieved on: 
Wednesday, October 26, 2022
Data collection, Health care, Technology, List of life sciences, VP, Gaps, NYSE, Intelligence, Professional services, Research, Mainland Chinese, DWPI, Industry, Geography, White, Collection, Invention, Infrastructure, Derwent World Patents Index, Web of Science, CEO, Ecosystem, IP, Patent, Clarivate, Innovation, Overalls, Academy, Final good, Derwent, Policy, Solution, Fraunhofer Institute for Systems and Innovation Research ISI, Renewable energy, Weapon

LONDON, Oct. 26, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report, A study of energy in transition: the role of research and innovation in the world's shift to sustainable energy sources. It finds that innovation activity in the sustainable energy space is tailing off, as research and inventive activities for respective renewable develops at different paces. This finding is based on Clarivate data normalized for overall increases in scientific journal and patent output increases globally in all subject areas.

Key Points: 
  • It finds that innovation activity in the sustainable energy space is tailing off, as research and inventive activities for respective renewable develops at different paces.
  • Oceanic power generation currently falls within the immature scale of the report's sustainable energy sources maturity index,2despite oceanic power, with its high energy density, being seen as one of the most promising sustainable energy sources if fully harnessed.
  • From a geographic perspective, Mainland China tops global research and innovation output in renewable energy sources, strengthening its international stature as a research and innovation powerhouse.
  • It looks at the relationship between global research and innovation in the roll out and development of sustainable energy sources.

ESFM deploys proprietary technology platform, simplifying siloed facilities management programs with one innovative solution

Retrieved on: 
Tuesday, October 25, 2022
CMMS, LinkedIn, International, Building management system, Feedback, IFM, Fortune, Name, Efficiency, List of life sciences, Lilly, QA, Forbes, Education, Organization, Diversity, HVAC, BMS, GDI Integrated Facility Services, Multimedia, History, Fortune 500, Industry, IFMA, Foodservice, International Facility Management Association, Workplace, Compass Group, Keystone, Facility management, Benchmarking, Computerized maintenance management system, ESFM, Solution, AutoCAD, Audit, Technology, Compass

CHARLOTTE, N.C., Oct. 25, 2022 /PRNewswire/ -- To simplify life for the client, building end-user and facilities manager, ESFM developed ESFMx to perform a broad range of functions within a single, fully integrated solution.

Key Points: 
  • ESFMx is secure and scalable and was developed in collaboration with the ESFM operations team, who oversee a self-performed Integrated Facilities Management model across the country.
  • "ESFM prides itself on the fact that we self-perform over 80% of the hard and soft services we provide clients.
  • ESFMx addresses all services efficiently consolidating siloed technology, while elevating the workplace experience with data-driven self-performed solutions.
  • In 2020, ESFM (formerly Eurest Services) won the George Graves Award for Facility Management Achievement from the International Facilities Management Association (IFMA).

ANGUS LAUNCHES COMMERCIAL PRODUCTION OF HEPES BUFFER

Retrieved on: 
Tuesday, October 25, 2022
ISO, HEPES, ISO 9001:2015, Biotechnology, Cell, Deoxyribonuclease, Immunoprecipitation, Company, ANGUS, Multi, CEO, Buffer, Tris, AMP, INCI, Ribonuclease, TRIS, List of life sciences, Fine chemical

BUFFALO GROVE, Ill., Oct. 25, 2022 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the commercial launch of HEPES buffer produced at its Sterlington, Louisiana facility.

Key Points: 
  • BUFFALO GROVE, Ill., Oct. 25, 2022 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the commercial launch of HEPES buffer produced at its Sterlington, Louisiana facility.
  • HEPES is multi-purpose biological buffer often used to maintain a physiological pH which provides the ideal environment for cells to grow and thrive.
  • HEPES buffer (INCI: Hydroxyethylpiperazine Ethane Sulfonic Acid) can also be used in combination with other ingredients to support the quality and performance of skincare and cosmetics products.
  • "The expansion into commercial production of HEPES is a natural fit with our strategy to become the world's most transparent and dependable manufacturer of essential upstream and downstream bioprocessing chemistries," said ANGUS President and CEO David Neuberger.

BlueDot announces new leadership as it prepares for rapid growth in 2023

Retrieved on: 
Tuesday, October 25, 2022
Infection, CDC, Growth, COVID, Medtech, Roche, COVID 19, Intelligence, Private sector, Air Canada, Veterinary medicine, Publication, Monkeypox, Master, Doctor of Philosophy, Industry, AI, CEO, Leadership, Porter Airlines, Philips, BlueDot, Union Pearson Express, City, Taiwan, COVID-19, List of life sciences, Management, Pharmaceutical industry, Taiwan Centers for Disease Control, Marketing, Epidemiology

TORONTO, Oct. 25, 2022 /PRNewswire-PRWeb/ -- BlueDot Inc., the leading artificial and human intelligence organization for detecting, assessing, and responding to global infectious diseases, announced the expansion of its executive team as it enters its next phase of growth. As part of the company's continued work in building private and public sectors' resiliency to outbreaks, BlueDot announced the hires of Les Lengyel, Vice President of Sales and Jannine Krish, Vice President of Marketing, in addition to the promotion of Dr. Andrea Thomas to Director of Epidemiology.

Key Points: 
  • With over a decade in Philips Healthcare and Roche respectively alone, he brings a critical understanding of how to drive successful key initiatives and company growth.
  • Through a combination of storytelling and performance marketing, she's led marketing strategies that build industry leadership, consumer trust and business results.
  • Dr. Andrea Thomas has been a predominant figure in driving excellence in epidemiology at BlueDot over the past five years.
  • "Our company went through a rapid phase of growth during the height of the COVID 19 pandemic," said Dr. Kamran Khan, Founder and CEO, BlueDot.